Abbott, AbbVie Hit With $2.2M Verdict In Humira Suit

Law360, New York (May 9, 2013, 7:28 PM EDT) -- A Chicago jury slapped Abbott Laboratories and AbbVie Inc. with a $2.2 million verdict Thursday in a suit brought by a man whose wife allegedly suffered a life-threatening fungal infection as a result of taking the blockbuster arthritis drug Humira.

The state court jury found for plaintiff Milton Tietz on his negligence claim, though it found for the companies on a product defect claim, according to Jim Perdue Jr. of Perdue Kidd & Vickery, an attorney for Tietz. Abbott spun off AbbVie earlier this year....
To view the full article, register now.